Serum tumor necrosis factor-alpha level in hepatitis E virus-related acute viral hepatitis and fulminant hepatic failure in pregnant women

Hepatology Research

Volumn 43, Issue 8, 2013, Pages 826-835

  Salam, Gyaneshwori Devi ^a   Kumar, Ashok ^a   Kar, Premashis ^a   Aggarwal, Sarita ^a   Husain, Akhtar ^b   Sharma, Shashi ^c  

^a MAULANA AZAD MEDICAL COLLEGE   (India)

^b JAMIA MILLIA ISLAMIA CENTRAL UNIVERSITY   (India)

^c INSTITUTE OF CYTOLOGY AND PREVENTIVE ONCOLOGY   (India)

Author keywords

Acute viral hepatitis; Fulminant hepatic failure; Hepatitis E virus; Non pregnant; Pregnant; Tumor necrosis factor

Indexed keywords

TUMOR NECROSIS FACTOR ALPHA;

ABORTION; ARTICLE; BIRTH; CONTROLLED STUDY; ENZYME LINKED IMMUNOSORBENT ASSAY; FEMALE; FETUS DEATH; FULMINANT HEPATIC FAILURE; HEPATITIS A; HEPATITIS B; HEPATITIS C; HEPATITIS E; HEPATITIS E VIRUS; HUMAN; JAUNDICE; LOW BIRTH WEIGHT; MAJOR CLINICAL STUDY; NEWBORN DEATH; PREGNANCY OUTCOME; PREGNANT WOMAN; PREMATURE LABOR; PRIORITY JOURNAL; PROTEIN BLOOD LEVEL; SMALL FOR DATE INFANT;

EID: 84882639514     PISSN: 13866346     EISSN: 1872034X     Source Type: Journal    
DOI: 10.1111/hepr.12028     Document Type: Article

References (46)

1. Khuroo MS. Study of an epidemic of non-A, non-B hepatitis. Possibility of another human hepatitis virus distinct from post-transfusion non-A, non-B type. Am J Med 1980; 68: 818-824.
2. Khuroo MS. Acute liver failure in India [Letter]. Hepatology 1997; 26: 244-246.
3. Khuroo MS, Teli MR, Skidmore S, Soa MA, Khuroo MI. Incidence and severity of viral hepatitis in pregnancy. Am J Med 1981; 70: 252-255.
4. Krawczynski K, Aggarwal R, Kamili S. Hepatitis E. Infect Dis Clin North Am 2000; 14: 669-687.
5. Nayak NC, Panda SK, Datta R etal. Aetilogy and outcome of acute viral hepatitis in pregnancy. J Gastroenterol Hepatol 1989; 4: 345-352.
6. Patra S, Kumar A, Trivedi SS, Puri M, Sarin SK. Maternal and fetal outcomes in pregnant women with acute hepatitis E virus infection. Ann Intern Med 2007; 147: 28-33.
7. Khuroo MS, Kamili S. Aetiology, clinical course and outcome of sporadic acute viral hepatitis in pregnancy. J Viral Hepat 2003; 10: 61-69.
8. Khuroo MS, Kamili S. Association of severity of hepatitis E virus infection in mother and vertically transmitted infection in fetus. JK-Practitioner 2006; 13: 70-74.
9. Ostapowicz G, Fontana RJ, Schiodt FV etal. Results of a prospective study of acute liver failure at 17 tertiary care centers in the United States. Ann Intern Med 2002; 137: 947-954.
10. Bernal W. Changing patterns of causation and the use of transplantation in the United Kingdom. Semin Liver Dis 2003; 23: 227-237.
11. Kar P, Budhiraja S, Narang A, Chakravarthy A. Etiology of sporadic acute and fulminant non-A, non-B viral hepatitis in north India. Indian J Gastroenterol 1997; 16: 43-45.
12. Acharya SK, Panda SK, Saxena A, Gupta SD. Acute hepatic failure in India: a perspective from the East. J Gastroenterol Hepatol 2000; 15: 473-479.
13. Kumar A, Beniwal M, Kar P, Sharma JB, Murthy NS. Hepatitis E in pregnancy. Int J Gynaecol Obstet 2004; 85: 240-244.
14. de la Mata M, Meager A, Rolando N etal. Tumour necrosis factor production in fulminant hepatic failure: relation to aetiology and superimposed microbial infection. Clin Exp Immunol 1990; 82: 479-484.
15. Sekiyama KD, Yoshiba M, Thomson AW. Circulating proinflammatory cytokines (IL-1 beta, TNF-alpha, and IL-6) and IL-1 receptor antagonist (IL-1Ra) in fulminant hepatic failure and acute hepatitis. Clin Exp Immunol 1994; 98: 71-77.
16. Andus T, Bauer J, Gerok W. Effect of cytokines on the liver. Hepatology 1991; 13: 364-375.
17. Dinarello CA. Interleukin-l and interleukin-l antagonism. Blood 1991; 77: 1627-1652.
18. Anastassakos C, Alexander GJM, Wolstencroft RA etal. Interleukin-l and interleukin-2 activity in chronic hepatitis B virus infection. Gastroenterology 1988; 94: 999-1005.
19. Yoshioka K, Kakumu S, Arao M, Tstusumi Y, Inoue M. Tumor necrosis factor-e production by peripheral blood mononuclear cells of patients with chronic liver disease. Hepatology 1989; 10: 769-773.
20. Kakumu S, Shinagawa T, Ishikawa T etal. Serum interleukin-6 levels in patients with chronic hepatitis B. Am J Gastroenterol 1991; 86: 1804-1808.
21. Brockhaus M, Schoenfeld HJ, Schlaeger EJ, Hunziker W, Lesslauer W, Loetscher H. Identification of two types of tumor necrosis factor receptors on human cell lines by monoclonal antibodies. Proc Natl Acad Sci U S A 1990; 87: 3127-3131.
22. Hohmann HP, Remy R, Brockhaus M, van Loon AP. Two different cell types have different major receptors for human tumor necrosis factor (TNF alpha). J Biol Chem 1989; 264: 14927-14934.
23. Hunt JS, Chen HL, Miller L. Tumor necrosis factors: pivotal components of pregnancy? Biol Reprod 1996; 54: 554-562.
24. Raghupathy R. Th1-type immunity is incompatible with successful pregnancy. Immunol Today 1997; 18: 478-482.
25. Smedile A, Carcil FP, Verma G etal. Inference of delta infection on the severity of hepatitis B. Lancet 1982; 2: 945-947.
26. Trey C, Dandson LS. The management of fulminant hepatic failure. In: Popper H, Schaffiner F, eds. Progress in Liver Diseases, Vol. 3. New York: Grune and Statton, 1970; 282-298.
27. Nelson DR, Marousis CG, Davis GL etal. The role of hepatitis C virus-specific cytotoxic T lymphocytes in chronic hepatitis C. J Immunol 1997; 158: 1473-1481.
28. Chisari FV, Ferrari C. Hepatitis B virus immunopathology. Springer Semin Immunopathol 1995; 17: 261-281.
29. Naik S, Aggarwal R, Naik SR etal. Evidence for activation of cellular immune responses in patients with acute hepatitis E. Indian J Gastroenterol 2002; 21: 149-152.
30. Marzi M, Vigano A, Trabattoni D etal. Characterization of type 1 and type 2 cytokine production profile in physiologic and pathologic human pregnancy. Clin Exp Immunol 1996; 106: 127-133.
31. Reinhard G, Noll A, Schlebusch H, Mallmann P, Ruecker AV. Shifts in the TH1/TH2 balance during human pregnancy correlate with apoptotic changes. Biochem Biophys Res Commun 1998; 245: 933-938.
32. Saravanabalaji S, Tripathy AS, Dhoot RR, Chadha MS, Kakrani AL, Arankalle VA. Viral load, antibody titers and recombinant open reading frame 2 protein-induced TH1/TH2 cytokines and cellular immune responses in self-limiting and fulminant hepatitis e. Intervirology 2009; 52: 78-85.
33. Singhal S, Chakravarty A, Das BC, Kar P. Tumour necrosis factor-alpha and soluble Fas ligand as biomarkers in non-acetaminophen-induced acute liver failure. Biomarkers 2009; 14: 347-353.
34. Tilg H, Wilmar A, Vogel W etal. Serum levels of cytokines in chronic liver diseases. Gastroenterology 1992; 103: 264-274.
35. Wegmann TG, Lin H, Guilbert L, Mosmann TR. Bidirectional cytokine interactions in the maternal-fetal relationship: is successful pregnancy a TH2 phenomenon? Immunol Today 1993; 14: 353-356. Review.
36. Medawar PB. Some immunological and endocrinological problems raised by the evolution of viviparity in vertebrates. Symp Soc Exp Biol 1953; 7: 320-338.
37. Opsjon SL, Wathen NC, Tingulstad S etal. Tumor necrosis factor, interleukin-1, and interleukin-6 in normal human pregnancy. Am J Obstet Gynecol 1993; 169: 397-404.
38. Romero R, Gómez R, Chaiworapongsa T, Conoscenti G, Kim JC, Kim YM. The role of infection in preterm labour and delivery. Paediatr Perinat Epidemiol 2001; 15 (Suppl 2): 41-56.
39. Fortunato SJ, Menon R, Lombardi SJ. Role of tumor necrosis factor-alpha in the premature rupture of membranes and preterm labor pathways. Am J Obstet Gynecol 2002; 187: 1159-1162.
40. Inglis SR, Jeremias J, Kuno K etal. Detection of tumor necrosis factor-alpha, interleukin-6, and fetal fibronectin in the lower genital tract during pregnancy: relation to outcome. Am J Obstet Gynecol 1994; 171: 5-10.
41. Fortunato SJ, Menon R, Lombardi SJ. Support for an infection-induced apoptotic pathway in human fetal membranes. Am J Obstet Gynecol 2001; 184: 1392-1398.
42. Labarrere CA, Faulk WP. Immunopathology of human extraembryonic tissues. In: Coulam CB, Faulk WP, McIntyre JA, eds. Immunological Obstetrics. New York: WW Norton & Co, 1992; 439-463.
43. Tangri S, Wegmann TG, Lin H, Raghupathy R. Maternal anti-placental reactivity in natural, immunologically-mediated fetal resorptions. J Immunol 1994; 152: 4903-4911.
44. Yui J, Garcia-Lloret M, Wegmann TG, Guilbert LJ. Cytotoxicity of tumour necrosis factor-alpha and gamma-interferon against primary human placental trophoblasts. Placenta 1994; 15: 819-835.
45. Menon R, Lombardi SJ, Fortunato SJ. TNF-alpha promotes caspase activation and apoptosis in human fetal membranes. J Assist Reprod Genet 2002; 19: 201-204.
46. Knackstedt MK, Zenclussen AC, Hertwig K etal. Th1 cytokines and the prothrombinase fgl2 in stress-triggered and inflammatory abortion. Am J Reprod Immunol 2003; 49: 210-220.